EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Chromatin‐binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation

Marwah Mousa, Yue Liang, Lin Tze Tung, HanChen Wang, Connie Krawczyk iD, David Langlais, Anastasia Nijnik iD

Immunology · 2024-05 · 172 (1) · 109-126

DOI: 10.1111/imm.13758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, online erschienen am 05.02.2024. Verfasst von Marwah Mousa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Trans-Activators, Ubiquitin-Specific Proteases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Leukemia and Lymphoma Society of Canada, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendritic cells (DCs) are the most significant antigen presenting cells of the immune system, critical for the activation of naïve T cells. The pathways controlling DC development, maturation, and effector function therefore require precise regulation to allow for an effective induction of adaptive immune response. MYSM1 is a chromatin binding deubiquitinase (DUB) and an activator of gene expression via its catalytic activity for monoubiquitinated histone H2A (H2A‐K119ub), which is a highly abundant repressive epigenetic mark. MYSM1 is an important regulator of haematopoiesis in mouse and human, and a systemic constitutive loss of Mysm1 in mice results in a depletion of many haematopoietic progenitors, including DC precursors, with the downstream loss of most DC lineage cells. However, the roles of MYSM1 at the later checkpoints in DC development, maturation, activation, and effector function at present remain unknown. In the current work, using a range of novel mouse models ( Mysm1 fl Cre ERT2 , Mysm1 fl CD11c‐cre, Mysm1 DN ), we further the understanding of MYSM1 functions in the DC lineage: assessing the requirement for MYSM1 in DC development independently of other complex developmental phenotypes, exploring its role at the later checkpoints in DC maintenance and activation in response to microbial stimulation, and testing the requirement for the DUB catalytic activity of MYSM1 in these processes. Surprisingly, we demonstrate that MYSM1 expression and catalytic activity in DCs are dispensable for the maintenance of DC numbers in vivo or for DC activation in response to microbial stimulation. In contrast, MYSM1 acts via its DUB catalytic activity specifically in haematopoietic progenitors to allow normal DC lineage development, and its loss results not only in a severe DC depletion but also in the production of functionally altered DCs, with a dysregulation of many housekeeping transcriptional programs and significantly altered responses to microbial stimulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trans-ActivatorsUbiquitin-Specific ProteasesAnimalsHumansMiceCell DifferentiationChromatinDendritic CellsEndopeptidasesHistonesMice, Knockout

Stichwörter der Autor:innen

cell differentiationdendritic cellsflow cytometrygene regulationtransgenic/knockout mice

Substanzen

ChromatinEndopeptidasesHistonesMYSM1 protein, humanTrans-ActivatorsUbiquitin-Specific ProteasesMYSM1 protein, mouse

Autor:innen und Institutionen

  • Department of Physiology, McGill University, Montreal, Quebec, Canada.
  • McGill University Research Centre on Complex Traits, McGill University, Montreal, Quebec, Canada.
  • Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, Michigan, United States.
  • Department of Human Genetics, McGill University Genome Centre, McGill University, Montreal, Quebec, Canada.
  • Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Connie Krawczyk, Anastasia Nijnik

Förderung

  • CIHR
  • Leukemia and Lymphoma Society of Canada
  • Canadian Institutes of Health Research

Zitieren

APA

Mousa, M., Liang, Y., Tung, L. T., Wang, H., Krawczyk, C., Langlais, D., & Nijnik, A. (2024). Chromatin‐binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation. Immunology, 172(1), 109-126. https://doi.org/10.1111/imm.13758

Vancouver

Mousa M, Liang Y, Tung LT, Wang H, Krawczyk C, Langlais D, et al. Chromatin‐binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation. Immunology. 2024;172(1):109-126. doi:10.1111/imm.13758

BibTeX
@article{Mousa2024,
  author = {Mousa, Marwah and Liang, Yue and Tung, Lin Tze and Wang, HanChen and Krawczyk, Connie and Langlais, David and Nijnik, Anastasia},
  title = {Chromatin‐binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation},
  journal = {Immunology},
  year = {2024},
  volume = {172},
  number = {1},
  pages = {109--126},
  doi = {10.1111/imm.13758}
}
Kostenlos starten →